Unlock Early Insights into Large-Scale CHO Process Challenges

Explore how our pDS bioreactor system effectively mimics the complexities of large-scale CHO cell culture in a lab environment. In this case study, we scaled down a 12,000L bioreactor, replicating critical large-scale effects such as a 30% reduction in monoclonal antibody titer and a twofold increase in lactate production. These results align with known large-scale challenges, allowing early identification of potential issues before full-scale production.

 

 

 

Download the whitepaper to see how our scalable solution can enhance your bioprocess development and improve efficiency from lab to production.